• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素血清峰浓度监测。

Vancomycin peak serum concentration monitoring.

作者信息

Tam V H, Moore G E, Triller D M, Briceland L L

机构信息

Albany College of Pharmacy, New York, USA.

出版信息

J Intraven Nurs. 1999 Nov-Dec;22(6):336-42.

PMID:10865602
Abstract

Vancomycin is a glycopeptide antibiotic commonly used in the treatment of gram-positive bacterial infections. With the rising prevalence of resistant gram-positive bacterial infections in healthcare institutions and the advent of attempts to curb escalating medical cost, vancomycin is being used with increasing frequency in the homecare setting for infection management. In view of its variability in pharmacokinetics and the potential for toxicities, serum concentrations often are measured. This article reviews the pharmacology of vancomycin and suggests a practical approach to serum concentration monitoring in homecare.

摘要

万古霉素是一种糖肽类抗生素,常用于治疗革兰氏阳性菌感染。随着医疗机构中耐革兰氏阳性菌感染的患病率不断上升,以及控制医疗成本不断攀升的尝试出现,万古霉素在家庭护理环境中用于感染管理的频率越来越高。鉴于其药代动力学的变异性和毒性可能性,通常会测量血清浓度。本文综述了万古霉素的药理学,并提出了一种在家庭护理中监测血清浓度的实用方法。

相似文献

1
Vancomycin peak serum concentration monitoring.万古霉素血清峰浓度监测。
J Intraven Nurs. 1999 Nov-Dec;22(6):336-42.
2
[Optimal vancomycin serum level in Staphylococcus aureus infections?].
Med Mal Infect. 2006 Sep;36(9):439-42. doi: 10.1016/j.medmal.2006.07.016. Epub 2006 Oct 5.
3
Antibiotic and anti-infective agent use and administration in homecare.
J Intraven Nurs. 1998 Jan-Feb;21(1):50-8.
4
[Recent aspects of monitoring the dosage of aminoglycosides and vancomycin].[氨基糖苷类和万古霉素剂量监测的最新进展]
Bull Acad Natl Med. 1998;182(2):285-97; discussion 297-8.
5
[Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].[耐革兰氏阳性菌感染的治疗:糖肽类抗生素万古霉素和替考拉宁的价值]
Schweiz Med Wochenschr. 1993 Dec 18;123(50):2353-6.
6
Medicare reimbursement for home infusion therapy: a contributor to the development of community acquired vancomycin-resistant enterococci?医疗保险对家庭输液治疗的报销:是社区获得性耐万古霉素肠球菌发展的一个促成因素吗?
J Intraven Nurs. 1996 Mar-Apr;19(2):99-101.
7
Monitoring of serum vancomycin concentrations in pediatric patients with normal renal function.对肾功能正常的儿科患者血清万古霉素浓度的监测。
Acta Med Iran. 2010 Mar-Apr;48(2):91-4.
8
Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.万古霉素初始谷浓度与儿童革兰阳性菌感染患者结局的相关性。
Biol Pharm Bull. 2020;43(10):1463-1468. doi: 10.1248/bpb.b19-01003.
9
Pharmacokinetics of vancomycin in adult cancer patients.
J Oncol Pharm Pract. 2010 Dec;16(4):245-50. doi: 10.1177/1078155209355847. Epub 2009 Dec 16.
10
Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance.
Trends Microbiol. 1997 Jun;5(6):240-9. doi: 10.1016/S0966-842X(97)01051-2.